Hydroxychloroquine Sulfate 200 MG [Plaquenil]

DRUG2 trials

Sponsors

Taoyuan General Hospital, Institut de cancérologie Strasbourg Europe

Conditions

COVID19Coronavirus InfectionHematologic Malignancy

Phase 2

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

WithdrawnNCT04392128

Institut de cancérologie Strasbourg EuropeCOVID19, Hematologic Malignancy

Start: 2020-09-02End: 2020-09-02Updated: 2020-09-04

Unknown Phase

Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

CompletedNCT04384380

Taoyuan General HospitalCoronavirus Infection

Start: 2020-04-01End: 2020-05-31Updated: 2020-08-04